Advancing UK Regulatory Science Strategy in the Context of Global Regulation: a Stakeholder Survey
New study published in Therapeutic Innovation & Regulatory Science today (17th February 2021) from the Birmingham Health Partners Centre for Regulatory Science and Innovation
Background
The U…
Funding boost to research multimorbidity in hospital patients
Scientists have been given almost £4m to improve understanding of multimorbidity in hospital patients.
Research led by Newcastle University will focus on multiple long-term conditions in hospita…
New med-tech partnership to assess quality of life in clinical trials and care
BHP founder-member the University of Birmingham has today announced a partnership with med-tech company Aparito to co-develop digital platforms to assess patient quality of life and symptoms in cli…
Clinical trial confirms digoxin is effective for treatment of atrial fibrillation
A clinical trial has shown that digoxin has the same effect on physical wellbeing as beta-blockers when used to treat patients with permanent atrial fibrillation and symptoms of heart failure.
Bet…
‘Weak’ and ‘strong’ cells bonding boosts body’s diabetes fight
Scientists have broadened our understanding of how ‘weak’ cells bond with their more mature cellular counterparts to boost the body’s production of insulin – improving our knowledge of the processe…
Birmingham secures National Training Centre for the Advanced Therapies Skills Training Network
The National Horizons Centre, RoslinCT and the University of Birmingham have been selected to deliver high impact physical and digitally-delivered training courses as part of the growing ATSTN prog…